3 Key Takeaways
Plain English Summary- 01Core Finding
She underwent emergent posterior fossa decompression.
- 02Study Evidence
Study design used a clinical case insight protocol to track clinical outcomes.
- 03Practical Meaning
Benefits and risks vary by individual health history — discuss with a healthcare professional.
What This Means for You
She later stabilized with radiographic improvement and meaningful neurologic recovery. Expanded antibody testing later confirmed anti-GABA A receptor (anti-GABA A R) encephalitis. This case highlights fulminant cerebellitis as a life-threatening presentation of anti-GABA A R encephalitis and underscores the importance of early posterior fossa decompression, parallel diagnostic evaluation (including expanded antibody panels), and coordinated, time-sensitive immunotherapy escalation in select critically ill presentations.
The Discovery
A previously healthy 5-year-old girl had several days of fever/malaise followed by acute neurologic decline. Head CT demonstrated fulminant right cerebellitis with edema and fourth-ventricle effacement concerning for impending herniation. She underwent emergent posterior fossa decompression. CSF showed mild pleocytosis, and MRI revealed right cerebellar nonenhancing T2/fluid-attenuated inversion recovery hyperintense lesions with evolving supratentorial cortical involvement. Despite empiric antimicrobials and initial immunotherapy (high-dose IV methylprednisolone and tocilizumab followed by IV immunoglobulin/plasma exchange), she developed progressive neuroinflammation with new seizures and markedly elevated CSF IL-6, prompting escalation to additional IL-6-directed therapy with tocilizumab and rescue intrathecal dexamethasone.
How It Works, Simply
This neurology research focuses on antibodies · Immune response · Receptor targeting. Researchers evaluated it using a standard-of-care clinical practice · Clinical case insight at the clinical practice stage of medical research.
3 Key Takeaways
Clinical Takeaways- 01Core Finding
She underwent emergent posterior fossa decompression.
- 02Study Evidence
Study design used a clinical case insight protocol to track clinical outcomes.
- 03Practical Meaning
Benefits and risks vary by individual health history — discuss with a healthcare professional.
Biological Mechanism & Study Design
Study Design & Cohort
Clinical case insight
Standard-of-care clinical practice · Clinical case insight · Clinical Practice
Biological Pathway & Modality
Antibodies · Immune response · Receptor targeting
Intervention: Pearls & Oy-sters: Anti-GABA A Receptor Encephalitis Presenting as Fulminant
Experimental Findings & Endpoints
A previously healthy 5-year-old girl had several days of fever/malaise followed by acute neurologic decline.
Head CT demonstrated fulminant right cerebellitis with edema and fourth-ventricle effacement concerning for impending herniation. She underwent emergent posterior fossa decompression.
CSF showed mild pleocytosis, and MRI revealed right cerebellar nonenhancing T2/fluid-attenuated inversion recovery hyperintense lesions with evolving supratentorial cortical involvement. Despite empiric antimicrobials and initial immunotherapy (high-dose IV methylprednisolone and tocilizumab followed by IV immunoglobulin/plasma exchange), she developed progressive neuroinflammation with new seizures and markedly elevated CSF IL-6, prompting escalation to additional IL-6-directed therapy with tocilizumab and rescue intrathecal dexamethasone.
Clinical Translation & Practice Context
She later stabilized with radiographic improvement and meaningful neurologic recovery.
Expanded antibody testing later confirmed anti-GABA A receptor (anti-GABA A R) encephalitis. This case highlights fulminant cerebellitis as a life-threatening presentation of anti-GABA A R encephalitis and underscores the importance of early posterior fossa decompression, parallel diagnostic evaluation (including expanded antibody panels), and coordinated, time-sensitive immunotherapy escalation in select critically ill presentations.
The Bottom Line · Clinical Pearl
“This case highlights fulminant cerebellitis as a life-threatening presentation of anti-GABA A R encephalitis and underscores the importance of early posterior fossa decompression, parallel diagnostic evaluation (including expanded antibody panels), and coordinated, time-sensitive immunotherapy escalation in select critically ill presentations. She later stabilized with radiographic improvement and meaningful neurologic recovery.”
Published in Neurology · Current Stage: Clinical Practice
